Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
作者信息
Bergsagel D E, Robertson G L, Hasselback R
出版信息
Can Med Assoc J. 1968 Mar 16;98(11):532-8.
Abstract
摘要
相似文献
1
Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.环磷酰胺对晚期肺癌的作用及大剂量间歇性静脉注射的血液学毒性
Can Med Assoc J. 1968 Mar 16;98(11):532-8.
2
Changes in peripheral blood composition following single and repeated courses of intermittent cancer chemotherapy.间歇性癌症化疗单次及重复疗程后外周血成分的变化
Med Interne. 1982 Oct-Dec;20(4):289-94.
3
[Chemotherapy of lung cancer].
Sov Med. 1984(11):55-61.
4
Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.环磷酰胺、阿霉素和顺铂联合（CAP）化疗用于广泛期非小细胞肺癌
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):955-8.
5
[Treatment of lung cancer with Endoxan, with reference to the effect of massive intermittent administration].[用环磷酰胺治疗肺癌，参考大剂量间歇给药的效果]
Saishin Igaku. 1967 Aug;22(8):1808-20.
6
[Correlation between the number of monocytes and granulocytes in the peripheral blood in lung cancer patients].[肺癌患者外周血中单核细胞与粒细胞数量的相关性]
Probl Gematol Pereliv Krovi. 1976 Dec;21(12):23-6.
7
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.环磷酰胺、阿霉素和顺铂治疗晚期非小细胞肺癌
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):941-5.
8
[Effect of toxic doses of selected antineoplastic drugs on the hematopoietic system of mice after splenectomy].[脾切除术后选定抗肿瘤药物的毒性剂量对小鼠造血系统的影响]
Acta Haematol Pol. 1980 Jul-Sep;11(3):181-7.
9
10
[Chemotherapy of lung cancer].[肺癌的化疗]
Vopr Onkol. 1972;18(9):82.
引用本文的文献
1
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.用于体内研究的免疫抑制：最新方案与实验方法
Cell Mol Immunol. 2017 Feb;14(2):146-179. doi: 10.1038/cmi.2016.39. Epub 2016 Oct 10.
2
Clinical pharmacokinetics of cyclophosphamide.环磷酰胺的临床药代动力学
Clin Pharmacokinet. 2005;44(11):1135-64. doi: 10.2165/00003088-200544110-00003.
3
An assessment of massive-dose chemotherapy of malignant disease.恶性疾病大剂量化疗的评估
Can Med Assoc J. 1971 Jan 9;104(1):31-6.
4
5
Reaction of human granulopoiesis to high-dose cyclophosphamide therapy.
Blut. 1979 Jan 22;38(1):9-16. doi: 10.1007/BF01082923.
6
Clinical pharmacokinetics of cyclophosphamide.环磷酰胺的临床药代动力学
Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94. doi: 10.2165/00003088-197904050-00004.
本文引用的文献
1
2
CONTROLLED STUDIES OF THE THERAPY OF NONRESECTABLE CANCER OF THE LUNG. I. METHODOLOGY.不可切除肺癌治疗的对照研究。I. 方法学。
Ann Thorac Surg. 1965 Jan;1:25-32. doi: 10.1016/s0003-4975(10)66718-5.
3
Nitrogen mustard and the steroid hormones in the treatment of inoperable bronchogenic carcinoma.
Am J Med. 1960 Dec;29:1008-16. doi: 10.1016/0002-9343(60)90081-4.
4
[Pharmacological characterization of cyclic nitrogen mustard phosphamide esters as cancer therapeutic agents].[环磷酰胺氮芥酯类作为癌症治疗药物的药理学特性]
Arzneimittelforschung. 1958 Jan;8(1):1-9.
5
Determination of human body surface area from height and weight.根据身高和体重测定人体表面积。
J Appl Physiol. 1954 Jul;7(1):1-12. doi: 10.1152/jappl.1954.7.1.1.
6
Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to 5-fluorouracil.不同增殖状态的造血集落形成细胞对5-氟尿嘧啶敏感性的比较
J Natl Cancer Inst. 1967 Mar;38(3):401-5.
7
Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine.不同增殖状态的造血集落形成细胞对长春碱敏感性的比较。
J Natl Cancer Inst. 1967 Mar;38(3):393-9.
8
9
An in vitro assay for growth-inhibiting activity of vinblastine.长春碱生长抑制活性的体外测定。
J Natl Cancer Inst. 1965 Nov;35(5):851-6.
Zotero 插件